Cargando…

Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region

INTRODUCTION: The clinical, social, and economic burden of epilepsy is undeniable. Local guidance on epilepsy management is limited and needed to address the both use of anti-seizure medication (ASM) and switching practices which influence clinical outcomes. AREAS COVERED: An expert panel composed o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsaadi, Taoufik, Almadani, Abubaker, Al-Hashel, Jasem, Al Salti, Abdullah, Melikyan, Gayane, Khan, Riaz Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310631/ https://www.ncbi.nlm.nih.gov/pubmed/37222860 http://dx.doi.org/10.1007/s40120-023-00491-8

Ejemplares similares

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Generic versus brand-name drugs used in cardiovascular diseases
por: Manzoli, Lamberto, et al.
Publicado: (2015)

Generics versus brand-named drugs for glaucoma: the debate continues
por: Bhartiya, Shibal, et al.
Publicado: (2020)

Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
por: Bosak, Magdalena, et al.
Publicado: (2017)

Elemental impurities analysis in name-brand and generic omeprazole drug samples
por: Pinheiro, Fernanda C., et al.
Publicado: (2020)

Comparison of Pharmaceutical Characteristics between Brand-Name Meropenem and Its Generics
por: Yang, Ping, et al.
Publicado: (2021)

Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study
por: Akhtar, Saeed, et al.
Publicado: (2023)

Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008)

What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice
por: Steinman, Michael A., et al.
Publicado: (2007)

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
por: Sarpatwari, Ameet, et al.
Publicado: (2016)

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
por: Ochi, Nobuaki, et al.
Publicado: (2014)

A Multidisciplinary Perspective Addressing the Diagnostic Challenges of Late-Onset Pompe Disease in the Arabian Peninsula Region Developed From an Expert Group Meeting
por: Al Shehri, Ali, et al.
Publicado: (2022)

Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels
por: Brito, Juan P., et al.
Publicado: (2020)

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
por: Malvankar-Mehta, Monali S, et al.
Publicado: (2019)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
por: Alsaadi, Taoufik, et al.
Publicado: (2022)

Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline
por: Oguri, Gaku, et al.
Publicado: (2023)

Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020)

Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
por: van der Meersch, Amélie, et al.
Publicado: (2011)

Effect of Generic vs. Brand-Name Meropenem on Mortality in a Colombian Hospital’s Intensive Care Unit
por: Feinstein, Max, et al.
Publicado: (2017)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Generic versus brand-name over-the-counter analgesics: knowledge and attitudes among Swedish pharmacy customers
por: Håkonsen, Helle, et al.
Publicado: (2020)

Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018
por: Lin, Shuo-yu, et al.
Publicado: (2021)

Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia
por: Ordóñez, Karen, et al.
Publicado: (2019)

Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
por: Inshasi, Jihad, et al.
Publicado: (2023)

Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017)

Brand Suicide? Memory and Liking of Negative Brand Names
por: Guest, Duncan, et al.
Publicado: (2016)

Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
por: Alsaadi, Taoufik, et al.
Publicado: (2023)

Generic names in Magnaporthales
por: Zhang, Ning, et al.
Publicado: (2016)

Comparison of the Effects of a Brand-name Drug and Its Generic Drug on the Quality of Life of Alzheimer’s Disease Patients
por: Sakakibara, Mikio, et al.
Publicado: (2015)

Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
por: Woo, Young Sup, et al.
Publicado: (2015)

Differences in the rheological properties and mixing compatibility with heparinoid cream of brand name and generic steroidal ointments: The effects of their surfactants
por: Kitagawa, Shuji, et al.
Publicado: (2016)

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims
por: Desai, Rishi J., et al.
Publicado: (2019)

Investigation of the efficacy of generic and brand-name salmeterol/fluticasone combination in the management of asthma: a randomized comparative trial
por: Panahi, Yunes, et al.
Publicado: (2018)

Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan
por: Hsu, Chih-Wei, et al.
Publicado: (2020)

Brands, networks, communities: How brand names are wired in the mind
por: Kovács, László, et al.
Publicado: (2022)

Are brand names special words? Letter visual‐similarity affects the identification of brand names, but not common words
por: Perea, Manuel, et al.
Publicado: (2022)

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2015)

Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia
por: Polić-Vižintin, Marina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_blsojk6met9s22tpq156plms41